[en] Imazalil (IMA) is a widely used imidazole-antifungal pesticide and. therefore. a food contaminant. This compound is also used as a drug (enilconazole). As intestine is the first site of exposure to ingested drugs and pollutants, we have investigated the effects of IMA, at realistic intestinal concentrations, on xenobiotic-metabolizing enzymes and efflux pumps by using Caco-2 cells, as a validated in vitro model of the human intestinal absorptive epithelium. For comparison, other conazole fungicides, i.e. ketoconazole, propiconazole and tebuconazole. were also studied. IMA induced cytochrome P450 (CYP) 1A1 activity to the same extent as benzo(a)pyrene (B(a)P) or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), in a dose-and time-dependent manner. Cell-free aryl hydrocarbon receptor (AhR) binding assay and reporter gene assay suggested that IMA is not an AhR-ligand, implying that IMA-mediated induction should involve an AhR-independent pathway. Moreover, IMA strongly inhibited the CYP3A4 activity in 1,25-vitamin D-3-induced Caco-2 cells. The other fungicides had weak or nil effects on CYP activities. Study of the apical efflux pump activities revealed that ketoconazole inhibited both P-glycoprotein (Pgp) and multidrug resistance-associated protein 2 (MRP-2) or breast cancer resistance protein (BCRP), whereas IMA and other fungicides did not. Our results imply that coingestion of IMA-contaminated food and CYP3A4- or CYP1A1-metabolizable drugs or chemicals could lead to drug bioavailability modulation or toxicological interactions, with possible adverse effects for human health. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Sergent, Thérèse
Dupont, Isabelle
Jassogne, Coralie
Ribonnet, Laurence
Van Der Heiden, Edwige ; Université de Liège - ULiège > Département de sciences des denrées alimentaires > Département de sciences des denrées alimentaires
Scippo, Marie-Louise ; Université de Liège - ULiège > Département de sciences des denrées alimentaires > Analyse des denrées alimentaires
Muller, Marc ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
McAlister, Dan
Pussemier, Luc
Larondelle, Yvan
Schneider, Yves-Jacques
Language :
English
Title :
CYP1A1 induction and CYP3A4 inhibition by the fungicide imazalil in the human intestinal Caco-2 cells-Comparison with other conazole pesticides
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Almi B., Egaas E., Christiansen A., Eklo O., Lode O., and Källqvist T. Effects of three fungicides alone and in combination on glutathione S-transferase activity (GST) and cytochrome P-450 (CYP 1A1) in the liver and gill of brown trout (Salmo trutta). Mar. Environ. Res. 54 (2002) 237-240
Baldwin S., Bloomer J., Smith G., Ayrton A., Clarke S., and Chenery R. Ketoconazole and sufaphenazole as the respective selective inhibitors of P4503A and 2C9. Xenobiotica 25 (1995) 261-270
Bates D., and Yu D. Clinical impact of drug-drug interactions with systemic azole antifungals. Drugs Today 39 (2003) 801-813
Berger V., Gabriel A.F., Sergent T., Trouet A., Larondelle Y., and Schneider Y.J. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP-2). Toxicol. Lett. 140 141 (2003) 465-476
Buesen R., Mock M., Seidel A., Jacob J., and Lampen A. Interaction between metabolism and transport of benzo(a)pyrene and its metabolites in enterocytes. Toxicol. Appl. Pharmacol. 183 (2002) 168-178
Chan L., Lowes S., and Hirst B. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 21 (2004) 25-51
De Waard P., de Kok T., Maas L., Peijnenburg A., Hoogenboom R., Aarts J., and van Schooten F. Influence of TCDD and natural Ah receptor agonists on benzo(a)pyrene-DNA adduct formation in the Caco-2 human colon cell line. Mutagenesis 23 (2008) 67-73
Eagling V., Tjia J., and Back D. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br. J. Clin. Pharmacol. 45 (1998) 107-114
EFSA. Opinion of the scientific panel on plant protection products and their residues on a request from the commission on the acute reference dose (ARfD) for imazalil. EFSA J. 460 (2007) 1-15
Egaas E., Sandvik M., Fjeld E., Källqvist T., Goksoyr A., and Svensen A. Some effects of the fungicide propiconazole on cytochrome P450 and glutathione S-transferase in brown trout (Salmo trutta). Comp. Biochem. Physiol. 122 (1999) 337-344
Garrison P., Tullis K., Brouwer A., Giesy J.P., and Denison M.S. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7 8-tetrachlorodibenzo-p-dioxin-like chemicals. Fundam. Appl. Toxicol. 30 (1996) 194-203
Ghannoum M., and Rice L. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12 (1999) 501-517
Gibbs M., Baillie M., Shen D., Kunze K., and Thummel K. Persistent inhibition of CYP3A4 by ketocoanzole in modified Caco-2 cells. Pharm. Res. 17 (2000) 299-305
Gibbs M., and Hosea N. Factors affecting the clinical development of cytochrome P450 3A substrates. Clin. Pharmacokinet. 42 (2003) 969-984
Gibbs M., Thummel K., Shen D., and Kunze K. Inhibition of CYP3A in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression. Drug Metab. Dispos. 27 (1999) 180-187
Gooderis C., Coacci J., and Van den Mooter G. Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds. Eur. J. Pharm. Biopharm. (2007)
Greiner B., Eichelbaum M., Fritz P., Kreichgauer H., von Richter O., Zundler J., and Kroemer H. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest. 104 (1999) 147-153
Hajek K., Cook N., and Novak R. Mechanism of inhibition of microsomal drug metabolism by imidazole. J. Pharmacol. Exp. Ther. 223 (1982) 97-104
Halleux C., and Schneider Y.J. Iron absorption by intestinal epithelial cells. 1. Caco-2 cells cultivated in serum-free medium, on polyethylene terephtalate microporous membranes, as an in vitro model. In Vitro Cell Dev. Biol. 27A (1991) 293-302
Hebert M., Roberts J., Prueksaritanont T., and Benet L. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin. Pharmacol. Ther. 52 (1992) 453-457
Hunter J., Hirst B., and Simmons N. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm. Res. 10 (1993) 743-749
Kaminsky L., and Zhang Q.Y. The small intestine as a xenobiotic-metabolizing organ. Drug Metab. Dipos. 31 (2003) 1520-1525
Kenworthy K., Bloomer J., Clarke S., and Houston J. CYP3A4 drug interactions: correlation of 10 probe substrates. Br. J. Clin. Pharmacol. 48 (1999) 716-727
Korashy H., Shayeganpour A., Brocks D., and El-Kadi A. Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines. Toxicol. Sci. 97 (2007) 32-43
Lake B., Renwick A., Cunninghame M., Price R., Surry D., and Evans D. Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver. Toxicology 131 (1998) 9-20
Lown K., Mayo R., and Leichtman A. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin. Pharmacol. Ther. 62 (1997) 248-260
Maurice M., Pichard L., Daujat M., Fabre I., Joyeux H., Domergue J., and Maurel P. Effects of imidazole derivatives on cytochrome P450 from human hepatocytes in primary culture. FASEB J. 6 (1992) 752-758
McAlister D., Fern M., and Allen R. Rapid aryl hydrocarbon receptor based polymerase chain reaction screening assay for polychlorinated dibenzo-p-dioxins and furans in soil and sediment. Talanta 74 (2008) 992-997
Menegola E., Broccia M., Di Renzo F., and Giavini E. Dysmorphogenic effects of some fungicides derived from the imidazole on rat embryos cultured in vitro. Reprod. Toxicol. 21 (2006) 74-82
Murray M. Altered CYP expression and function in rsponse to dietary factors: potential roles in disease pathogenesis. Curr. Drug Metab. 7 (2006) 67-81
Muto N., Hirai H., Tanaka T., Itoh N., and Tanaka K. Induction and inhibition of cytochrome P450 isoforms by imazalil, a food contaminant, in mouse small intestine and liver. Xenobiotica 27 (1997) 1215-1223
Nakagawa Y., and Moore G. Cytotoxic effects of postharvest fungicides, ortho-phenylphenol, thiabendazole and imazalil, on isolated rat hepatocytes. Life Sci. 57 (1995) 1433-1440
Navas J.M., Chana A., Herradon B., and Segner H. Induction of cytochrome P4501A (CYP1A) by clotrimazole, a non-planar aromatic compound. Computational studies on structural features of clotrimazole and related imidazole derivatives. Life Sci. 76 (2004) 699-714
Nebert D., Dalton T., Okey A., and Gonzalez F. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279 (2004) 23847-23850
Ortelli D., Edder P., and Corvi C. Pesticides residues survey in citrus fruits. Food Addit. Contam. 22 (2005) 423-428
Paine M., Schmiedlin-Ren P., and Watkins P. Cytochrome P-450 1A1 expression in human small bowel: interindividual variation and inhibition by ketoconazole. Drug Metab. Dispos. 27 (1999) 360-364
Paine M., Shen D., Kunze K., Perkins J., Marsh C., McVicar J., Barr D., Gillies B., and Thummel K. First-pass metabolism of midazolam by the human intestine. Clin. Pharmacol. 60 (1996) 14-24
Pea F., and Furlanut M. Pharmacokinetic aspects of treating infections in the intensive care unit. Clin. Pharmacokinet. 40 (2001) 833-868
Pennati R., Gropelli S., Zega G., Biggiogero M., De Bernardi F., and Sotgia C. Toxic effects of two pesticides, imazalil and triadimefon, on the early development of the ascidian Phallusia mammillata (Chordata Ascidiacea). Aquat. Toxicol. 79 (2006) 205-212
Pohl C., Will F., Dietrich H., and Schrenk D. Cytochrome P450 1A1 expression and activity in Caco-2 cells: modulation by apple juice extract and certain apple polyphenols. J. Agric. Food Chem. 54 (2006) 10262-10268
Rodriguez A., Lewis D., Ioannides C., and Parke D. Spectral and kinetic studies of the interaction of imidazole anti-fungal agents with microsomal cytochromes P-450. Xenobiotica 17 (1987) 1315-1327
Ronis M., Celander M., and Badger T. Cytochrome P450 enzymes in the kidney of the bobwhite quail (Colinus virginianus): induction and inhibition by ergosterol biosynthesis inhibiting fungicides. Comp. Biochem. Physiol. 121 (1998) 221-229
Ronis M., Ingelman-Sundberg M., and Badger T. Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). Biochem. Pharmacol. 48 (1994) 1953-1965
Sanderson T., Boerma J., Lansbergen G., and van den Berg M. Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicol. Appl. Pharmacol. 182 (2002) 44-54
Schmiedlin-Ren P., Thummel K., Fisher J., Paine M., Lown K., and Watkins P. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1-α 25-dihydroxyvitamin D3. Mol. Pharmacol. 51 (1997) 741-754
Schneider Y.J. Optimisation of hybridoma cell growth and monoclonal antibody secretion in a chemically defined serum- and protein-free culture medium. J. Immunol. Methods 116 (1989) 65-77
Schrickx J., Lektarau Y., and Fink-Gremmels J. Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Arch. Toxicol. 80 (2006) 243-249
Schuster I. The interaction of representative members from two classes of antimycotics - the azoles and the allylamines - with cytochromes P-450 in the steroidogenic tissues and liver. Xenobiotica 15 (1985) 529-546
Scippo M.L., Eppe G., De Pauw E., and Maghuin-Rogister G. DR-CALUX® screening of food samples: evaluation of the quantitative approach to measure dioxin, furans and dioxin-like PCBs. Talanta 63 (2004) 1193-1202
Sergent-Engelen T., Delistrie V., and Schneider Y.J. Phase I and II biotransformations in living Caco-2 cells cultivated under serum-free conditions. Biochem. Pharmacol. 46 (1993) 1393-1401
Sergent T., Garsou S., Schaut A., De Saeger S., Pussemier L., Van Peteghem C., Larondelle Y., and Schneider Y.J. Differential modulation of ochratoxin A absorption across Caco-2 cells by dietary polyphenols, used at realistic intestinal concentrations. Toxicol. Lett. 159 (2005) 60-70
Sergent T., Parys M., Garsou S., Pussemier L., Schneider Y.J., and Larondelle Y. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol. Lett. 164 (2006) 167-176
Sergent T., Ribonnet L., Jassogne C., Dupont I., Van Der Heiden E., Scippo M.L., Larondelle Y., Pussemier L., and Schneider Y.J. Imazalil modulates CYPs 1A1 and 3A4 activities in the human Caco-2 cells as an intestinal model to assess food safety. Toxicol. Lett. 172 (2007) S96-S196
Sergent T., Ribonnet L., Kolosova A., Garsou S., Schaut A., De Saeger S., Van Peteghem C., Larondelle Y., Pussemier L., and Schneider Y.J. Molecular and cellular effects of food contaminants and secondary plant components and their plausible interactions at the intestinal level. Food Chem. Toxicol. 46 (2008) 813-841
Siegel M., and Ragsdale N. Antifungal mode of action of imazalil. Pestic. Biochem. Physiol. 9 (1978) 48-56
Stiller R., and Stevens D. Studies with a plant fungicide, imazalil, with vapor-phase activity, in the therapy of human alternariosis. Mycopathologia 93S (1986) 169-172
Sun G., Thai S.F., Tully D., Lambert G., Goetz A., Wolf D., Dix D., and Nesnow S. Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver. Toxicol. Lett. 155 (2005) 277-287
Suzuki S., Kurata N., Nishimura Y., Yasuhara H., and Satoh T. Effects of imidazole antimycotics on the liver microsomal cytochrome P450 isoforms in rats: comparison of in vitro and ex vivo studies. Eur. J. Drug Metab. Pharmacokinet. 25 (2000) 121-126
Takano M., Hasegawa R., Fukuda T., Yumoto R., Nagai J., and Murakami T. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. Eur. J. Pharmacol. 358 (1998) 289-294
Takano M., Yumoyo R., and Murakami T. Expression and function of efflux drug transporters in the intestine. Pharmacol. Ther. 109 (2006) 137-161
Thienpont D., Van Cutsem J., Van Cauteren M., and Marsboom T. The biological and toxicological properties of imazalil. Arznei. Forsch. /Drug Res. 31 (1981) 309-315
Vanden Bossche H., Engelen M., and Rochette F. Antifungal agents of use in animal health-chemical, biochemical and pharmacological aspects. J. Vet. Pharmacol. Ther. 26 (2003) 5-29
Vanden Bossche H., Marichal P., Gorrens J., Bellens D., Verhoeven H., Coene M.C., Lauwers W., and Janssen P. Interaction of azole derivatives with cytochrome P450 isozymes in yeast, fungi, plants and mammalian cells. Pestic. Sci. 21 (1987) 289-306
Van der Heiden, E., Bechoux, N., Muller, M., Sergent, T., Schneider, Y.J., Larondelle, Y., Maghuin-Rogister, G., Scippo, M.L., 2008. Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays. Anal. Chim. Acta., doi:10.1016/j.aca.2008.09.054.
Venkatakrishnan K., von Moltke L., and Greenblatt D. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance. Clin. Pharmacokinet. 38 (2000) 111-180
Vinggaard A., Hnida C., Breinholt V., and Larsen J. Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicol. In Vitro 14 (2000) 227-234
Wacher V., Salphati L., and Benet L. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Del. Rev. 46 (2001) 89-102
Wang R.W., Newton D.J., Liu N., Atkins W.M., and Lu A.Y. Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent. Drug Metab. Dispos. 28 (2000) 360-366
Wen X., Walle K., and Walle T. 5 7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis 26 (2005) 803-809
WHO. GEMS/Food regional diets (2003), World health Organization, Food Safety Department, Geneva pp. 1-27
Xue W., and Warshawsky D. Metabolic activation of polycyclic and hetrocyclic aromatic hydrocarbons and DNA damag: a review. Toxicol. Appl. Pharmacol. 206 (2005) 73-93
Zarn J., Bruschweiler B., and Schlatter J. Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14alpha-demethylase and aromatase. Environ. Health Perspect. 111 (2003) 255-261
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
